Cost-effectiveness of insulin glargine compared to other long-acting basal insulins in the treatment of Finnish type 1 and type 2 diabetes patients based on individual studies


Autoria(s): Hallinen, Taru; Soini, Erkki; Asseburg, Christian; Suominen, Ritva; Laine, Hanna
Data(s)

05/03/2014

05/03/2014

2012

Identificador

Dosis 28 (2012) : 2, s. 145-164

0783-4233

URN:NBN:fi:ELE-1584738

http://www.doria.fi/handle/10024/95082

http://elektra.helsinki.fi/se/d/0783-4233/28/2/costeffe.pdf

Publicador

Helsinki : Suomen farmasialiitto

Relação

Dosis 28 (2012) : 2

10024/71967

Direitos

Elektra material, restricted access

Elektra-aineisto, rajattu käyttöoikeus

Elektra-material, begränsad tillgång

Palavras-Chave #glargiini #NPH-insuliini #detemir